FDA Investigator Sharon L Matson

Sharon L Matson has conducted inspections on 285 sites in 14 countries as of 27 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

285

Last Inspection Date:

27 May 2024

Investigator Role:

FDA Investigator

Redica ID:

100002961

Countries of Inspections:

United States of America, Spain, Canada, Germany, Italy, Australia, Georgia, Bosnia and Herzegovina, Austria, Poland, Japan, Sweden, Argentina, Malaysia

FDA Investigators that have inspected at least one site in common with Sharon L Matson:

Aaron L Dunbar, Aimee J Edwin, Albert L Nguyen, Alfred P Pistorio, Alison A Nicoli, Alison A Stone, Althea A Williams, Amber M Capello Jones, Amy L Mcintyre, Ana M Placencia, Andrea B Slavin, Annabelle Crusan, D,VM, Anthony J Ladner, April L Brown, April L Young, Benjamin J Dastoli, Benjamin W Anderson, Bill Tacket, Jr, Billi Jom Johnson, Carol Rivera Lopez, PhD, Carolyn A Warren, Charles R Cote, RIC, Cheron M Portee, Chester B Whitley, Christina L Bigham, Christine M Parmentier, Corey K Reno, Courtney R Tiegs, Craig A Garmendia, Ct Viswanathan, PhD, Cynthia F Kleppinger, MD, Dacia E Quick, Dale A Nyberg, Darren D Holaday, Demetria L Lueneburg, Denise D Dion, Denise L Burosh, Denise M Digiulio, Diane Cvan Leeuwen, Dolores Harper, Douglas W Atkins, Dr. Gopa Biswas, PhD, Dr. Hansong Chen, PhD, Elizabeth E Hart (ASCP), MT, Eric M Padgett, Eric S Myskowski, Eric T Huebler, Fannie M Harrell, Gregory A Berg, Gregory S Larson, Gregory W Smith, Howard A Burmester, Hugh M Mcclure, II, Ivan E Reyes, Jaclyn N Munsch, James A Beaulieu, James M Kewley, James P Mcevoy, Jan L Hewett, Jane E Nelson, Janis R Armedoriz, Jay V Jariwala, Jeanne M Morris, Jennifer A Longie Vollom, Jennifer Al Vollon, Jennifer S Ness, Jessica L Johnson, Joan T Briones, Jocelyn M Muggli, Joey C West, John E Emmert, Jonathan G Swoboda, Jonee J Mearns, Joseph D Gong, Joseph M Edwin, Jyoti B Patel, PhD, Karen M Labounty, Karen M Montgomery (KMM), Kellie L Thommes, RN, Kellie L Westerbuhr, Kevin A Swiss, PhD, Kevin P Regan, Kimberly Lewandowski Walker, Kyle J Mccracken, Laiza V Garcia, Lisa M Lopez, Lori S Lawless, M Edith Snyder, Mada A Tautges, Margaret M Annes, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Mary A Millner, Matthew B Casale, Melissa D Kalik, Melissa I Michurski, Mildred J Tures, Msdap Gonzlezk, Nicole C Victoria, PhD, Nilufer M Tampal, PhD, Norman Wong, Paola E Lathrop, Ralph Jerndal, Ralph W Jemdal, Rene R Ramirez, Rhonda L Mecl, Richard Jay Tucker, RS, Richard W Berning, Robert C Steyert, Ronald R Ruff, Ross J Grigsby, Ryan J Benedict, Sandra A Hughes, Sandra Sejdinovic, Scott A Golladay, Scott B Laufenberg, Shannon M Berg, Sharon K Thoma, PharmD, Sharon M Harold, Sripal R Mada, PhD, Stephanie Mangigian, MS/OSH, RN, Susan A Atcher, Susan M Atcher, Susan M Matthias, Tara C Singh, Timothy G Philips, Timothy R Marrs, Tony T Yang, Toyin B Oladimeji, Traci C Kelm, Tracy A Solseng, Tyler R Courtney, Wayne W Grundstrom, William E Keer, Xikui Chen (nmi), PhD, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Yoon K Oh, Yvette Mlacour Davis

Sharon L Matson's Documents

Publish Date	Document Type	Title
October, 2001	EIR	Orphan Medical, Inc. - EIR, 2001-01-09
July, 2002	EIR	Boston Scientific Corporation - EIR, 2002-07-25
October, 2001	EIR	Orphan Medical, Inc. - EIR, 2001-10-01
March, 2002	EIR	Lunde, N. Martin, MD, Clinical Investigator - EIR, 2002-03-26
April, 2019	FDA 483	Lauren R. Klein, MD, MS, Sponsor-Investigator - Form 483, 2019-04-23
June, 2007	FDA 483	Boston Scientific Corporation - Form 483, 2007-05-16
May, 2011	FDA 483	American Preclinical Services - Form 483, 2011-05-04
July, 2002	EIR	Boston Scientific Corporation - EIR, 2002-07-10
March, 2018	FDA 483 Response	Morie A. Gertz, M.D., Clinical Investigator - Form 483R, 2018-03-22
June, 2016	FDA 483 Response	Chhavi Chadha, MD - Form 483R, 2016-07-13
June, 2012	EIR	The Integra Group, Inc. - EIR, 2012-06-11
September, 2015	FDA 483 Response	U Of MN Research Subjects' Protection Program/ IRB - Form 483R, 2015-10-13
February, 2013	FDA 483	NAMSA - Form 483, 2013-02-04
April, 2000	EIR	Zavoral, James H., M.D., Clinical Investigator - EIR, 2000-04-19
July, 2000	FDA 483	[Clinic 42, Abbott Northwestern Hosp.] - Form 483, 2000-07-27
September, 2015	FDA 483	U Of MN Research Subjects' Protection Program/ IRB - Form 483, 2015-09-25
November, 2021	FDA 483	Boston Scientific Corporation - Form 483, 2021-11-18
March, 2021	FDA 483	Berman, Gary D., MD, Clinical Investigator - Form 483, 2021-03-29
September, 2015	EIR	U Of MN Research Subjects' Protection Program/ IRB - EIR, 2015-09-25
June, 2002	EIR	Boston Scientific Corporation - EIR, 2002-06-20
September, 2022	FDA 483	WuXi AppTec Inc. - Form 483, 2022-09-07
April, 2017	FDA 483	3M Company IRB - Form 483, 2017-04-14
August, 2012	FDA 483 Response	Miner, James R., MD, Clinical Investigator - Form 483R, 2012-08-31
June, 2010	EIR	Spineology, Inc. - EIR, 2010-06-30
January, 2005	EIR	Olson, Stephen, MD Clinical Investigator - EIR, 2005-01-26
December, 2005	FDA 483	Medtronic Heart Valve Division - Form 483, 2005-12-08
February, 2022	FDA 483	Samuel J. Maiser, M.D., Clinical Investigator - Form 483, 2022-02-11
April, 2024	FDA 483	Patrick S. Kamath, M.D., Clinical Investigator - Form 483, 2024-04-26
September, 2014	EIR	Patrick Flynn - EIR, 2014-09-05
June, 2000	EIR	Whitley, Chester B., Ph.D., M.D., Clinical Investigator - EIR, 2000-06-16
June, 2001	FDA 483	Steven E. Kempers, MD - Form 483, 2001-06-14
December, 2003	FDA 483	WuXi AppTec Inc. - Form 483, 2003-12-18
April, 2000	FDA 483	[Total Renal Research, Inc./CRU] - Form 483, 2000-04-07
March, 2020	FDA 483	Syntenza Pharmaceuticals, LLC - Form 483, 2020-03-12
August, 2018	FDA 483	Human Subjects Research Committee - Form 483, 2018-08-23
April, 2000	FDA 483	Zavoral, James H., M.D., Clinical Investigator - Form 483, 2000-04-19
March, 2023	FDA 483	John C. Lieske, M.D., Clinical Investigator - Form 483, 2023-03-03
April, 2015	FDA 483	PAREXEL International GmbH - Form 483, 2015-04-17
January, 2014	EIR	Hardten, David R., MD, Clinical Investigator - EIR, 2014-01-27
October, 2011	EIR	U Of MN Research Subjects' Protection Program/ IRB - EIR, 2011-10-18
June, 2010	FDA 483	Spineology, Inc. - Form 483, 2010-06-30
August, 2023	FDA 483	Paul Sorajja, M.D., Clinical Investigator - Form 483, 2023-08-28
July, 2000	EIR	Rhame, Frank S., M.D., Clinical Investigator - EIR, 2000-07-27
November, 2000	FDA 483	St. Jude Medical - Form 483, 2000-11-21
September, 2019	FDA 483	Anthony J. Windebank, M.D., Clinical Investigator - Form 483, 2019-09-19
February, 2023	FDA 483	Children's Healthcare IRB #1 - Form 483, 2023-02-03
October, 2019	EIR	Padagis US LLC - EIR, 2019-10-23
June, 2007	FDA 483 Response	Boston Scientific Corporation - Form 483R, 2007-05-16
June, 2016	EIR	Chhavi Chadha, MD - EIR, 2016-06-27
March, 2018	FDA 483	Morie A. Gertz, M.D., Clinical Investigator - Form 483, 2018-03-09
October, 2002	EIR	Henry, Keith W (M.D.) - EIR, 2002-10-28
March, 2005	FDA 483	Surpass, Inc. - Form 483, 2005-03-30
September, 2017	FDA 483	Boston Scientific Corporation - Form 483, 2017-09-22
September, 2014	FDA 483	Boston Scientific Corporation - Form 483, 2014-09-17
June, 2005	EIR	Medtox Laboratories, Inc. - EIR, 2005-06-28
March, 2022	FDA 483	HealthPartners Institute IRB - Form 483, 2022-03-14
February, 2000	FDA 483	CMAX - Form 483, 2000-02-29
February, 2021	FDA 483	Frank A. Sinicrope, M.D., Clinical Investigator - Form 483, 2021-02-26
September, 2005	EIR	Medtronic Physiological Research Lab - EIR, 2005-09-29
July, 2013	EIR	Allina Health [IRB] - EIR, 2013-07-01
July, 2002	FDA 483	Boston Scientific Corporation - Form 483, 2002-07-25
November, 2018	FDA 483	Boston Scientific Corporation - Form 483, 2018-11-16
February, 2000	EIR	CMAX Pty., Ltd., S.A. - EIR, 2007-02-08
September, 2005	FDA 483	Medtronic Physiological Research Lab - Form 483, 2005-09-29
December, 2001	EIR	3M Company - Health Care Business - EIR, 2001-12-06
November, 2017	FDA 483	Matson, Mark A., MD, Clinical Investigator, Prism Research - Form 483, 2017-11-15
December, 2004	EIR	3M Company - EIR, 2004-12-02
December, 2001	FDA 483 Response	3M Company - Health Care Business - Form 483R, 2002-02-20
March, 2017	FDA 483	Zogg, Donald L., M.D., Clinical Investigator - Form 483, 2017-03-01
September, 2014	EIR	Boston Scientific Corporation - EIR, 2014-09-17
June, 2017	EIR	Chester Whitely - EIR, 2017-06-29
October, 2001	FDA 483	Orphan Medical, Inc. - Form 483, 2001-01-10
August, 2018	FDA 483 Response	Human Subjects Research Committee - Form 483R, 2018-09-14
June, 2002	FDA 483	Boston Scientific Corporation - Form 483, 2002-06-20
September, 2018	FDA 483	Henry, W. Keith, M.D., Clinical Investigator - Form 483, 2018-09-19
October, 2002	FDA 483	HCMC - Form 483, 2002-10-28
September, 2014	FDA 483 Response	Boston Scientific Corporation - Form 483R, 2014-10-06
March, 2002	FDA 483	Lunde, N. Martin, MD, Clinical Investigator - Form 483, 2002-03-26
August, 2011	FDA 483	Dr. Indralingam Vaithilingam - Form 483, 2011-08-25
May, 2012	EIR	WuXi AppTec Inc. - EIR, 2012-05-01
December, 2001	FDA 483	3M Center - Form 483, 2001-12-06
September, 2022	EIR	WuXi AppTec Inc. - EIR, 2022-10-13
May, 2022	FDA 483	Kearney, Susan L., M.D., Clinical Investigator - Form 483, 2022-05-10
April, 2023	FDA 483	National Marrow Donor Program IRB - Form 483, 2023-04-04
October, 2019	FDA 483 Response	Padagis US LLC - Form 483R, 2019-11-07
June, 2012	FDA 483	The Integra Group, Inc. - Form 483, 2012-06-11
July, 2013	FDA 483	Allina Health [IRB] - Form 483, 2013-07-01
March, 2019	FDA 483	Abu Dayyeh, Barham, K., MD, MPH, Clinical Investigator - Form 483, 2019-03-05
June, 2001	EIR	Associated Skin Care Specialists PA - EIR, 2001-06-14
April, 2007	EIR	Schrock, Christian M.D. - EIR, 2007-04-10
March, 2018	EIR	Morie A. Gertz, M.D., Clinical Investigator - EIR, 2018-03-09
August, 2012	EIR	Miner, James R., MD, Clinical Investigator - EIR, 2012-08-23
December, 2003	EIR	WuXi AppTec Inc. - EIR, 2003-12-18
April, 2000	EIR	DaVita Clinical Research - EIR, 2000-04-07
October, 2001	FDA 483 Response	Orphan Medical, Inc. - Form 483R, 2001-02-06
November, 2000	FDA 483 Response	St. Jude Medical - Form 483R, 2000-12-01
April, 2024	FDA 483	Jessica A. Thomes-Pepin, M.D. - Form 483, 2024-04-08
June, 2024	FDA 483	Abbott - Form 483, 2024-06-28
August, 2024	FDA 483	Alexander Khoruts, M.D., Sponsor-Investigator - Form 483, 2024-08-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more